|Articles|August 1, 2004

Supplements and Featured Publications

  • Newsletter - Inflammation, Metabolic Syndrome, and CV Risk Reduction
  • Volume 10
  • Issue 2 Metab

CE / CME

CE: https://secure.pharmacytimes.com/courselist.asp?course_id=200408-03

CME: http://cme-online.med.upenn.edu

Articles in this issue

over 21 years ago

Commentary

over 21 years ago

Post Test

over 21 years ago

Faculty Disclosure Statement

over 21 years ago

Metabolic syndrome: A new target of therapy?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text